相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
Nigel J. Liverton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro
Sam Hopkins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α-2b and nucleoside analogues
Carolyn A. Luscombe et al.
ANTIVIRAL RESEARCH (2010)
Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
Henk W. Reesink et al.
GASTROENTEROLOGY (2010)
Identification of Hepatitis C Virus NS5A Inhibitors
Julie A. Lemm et al.
JOURNAL OF VIROLOGY (2010)
Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors
Lotte Coelmont et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor
Tse-I Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
Stephanie T. Shi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
David Masson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership
Marie Perrault et al.
BIOCHEMICAL JOURNAL (2009)
Cellular and molecular biology of HCV infection and hepatitis
Hengli Tang et al.
CLINICAL SCIENCE (2009)
Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C
Vinod K. Rustgi
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin
Jean-Francois Rossignol et al.
GASTROENTEROLOGY (2009)
The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C Patients
Robert Flisiak et al.
HEPATOLOGY (2009)
A Phase III Study of the Safety and Efficacy of Viramidine Versus Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C: ViSER1 Results
Yves Benhamou et al.
HEPATOLOGY (2009)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
Characterization of Resistance to the Protease Inhibitor Boceprevir in Hepatitis C Virus-Infected Patients
Simone Susser et al.
HEPATOLOGY (2009)
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
Hitomi Sezaki et al.
INTERVIROLOGY (2009)
The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
Udayan Chatterji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
Michela E. Burlone et al.
JOURNAL OF GENERAL VIROLOGY (2009)
SAFETY AND ANTIVIRAL EFFICACY OF 14 DAYS OF THE CYCOPHILIN INHIBITOR NIM811 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2a IN RELAPSED GENOTYPE 1 HCV INFECTED PATIENTS
E. Lawitz et al.
JOURNAL OF HEPATOLOGY (2009)
ANTIVIRAL ACTIVITY OF ANA598, A POTENT NON-NUCLEOSIDE POLYMERASE INHIBITOR, IN CHRONIC HEPATITIS C PATIENTS
E. Lawitz et al.
JOURNAL OF HEPATOLOGY (2009)
SAFETY, PLASMA PHARMACOKINETICS, AND ANTI-VIRAL ACTIVITY OF SCY-635 IN ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
S. Hopkins et al.
JOURNAL OF HEPATOLOGY (2009)
PARTICULAR IN VITRO ANTI-HCV ACTIVITIES AND RESISTANCE PROFILE OF THE CYCLOPHILIN INHIBITOR DEBIO 025
L. Coelmont et al.
JOURNAL OF HEPATOLOGY (2009)
Treatment failure in hepatitis C: Mechanisms of non-response
Andrew W. Tai et al.
JOURNAL OF HEPATOLOGY (2009)
RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS
Y. Benhamou et al.
JOURNAL OF HEPATOLOGY (2009)
EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
D. R. Nelson et al.
JOURNAL OF HEPATOLOGY (2009)
ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
G. R. Foster et al.
JOURNAL OF HEPATOLOGY (2009)
Substituted imidazopyridines as potent inhibitors of HCV replication
Inge Vliegen et al.
JOURNAL OF HEPATOLOGY (2009)
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor
Giuseppe Manfroni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure-Based Discovery of Triphenylmethane Derivatives as Inhibitors of Hepatitis C Virus Helicase
Chien-Shu Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor
Hui Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4
J. F. Rossignol et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide
Brent E. Korba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors
David L. Wyles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors
Wengang Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Combinations of cyclophilin inhibitor NIM811 with hepatitis C virus NS3-4A protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance
Joanna E. Mathy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
Scott D. Seiwert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Molecular mechanism of hepatitis C virus replicon variants with reduced susceptibility to a benzofuran inhibitor, HCV-796
Anita Y. M. Howe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479
Samir Ali et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to nonnucleoside polymerase or protease inhibitors
Matthew F. McCown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication
Brent E. Korba et al.
ANTIVIRAL RESEARCH (2008)
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C
Jean-Francois Rossignol et al.
FUTURE MICROBIOLOGY (2008)
Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
Peter Ferenci et al.
GASTROENTEROLOGY (2008)
R1626 plus peginterferon alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin
Paul J. Pockros et al.
HEPATOLOGY (2008)
High relapse rate seen at week 72 for patients treated with R1626 combination therapy
Paul Pockros et al.
HEPATOLOGY (2008)
The cyclophilin inhibitor debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
Robert Flisiak et al.
HEPATOLOGY (2008)
Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C
Stuart K. Roberts et al.
HEPATOLOGY (2008)
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Stefan Zeuzem
JOURNAL OF HEPATOLOGY (2008)
Targeting lipid metabolism in the treatment of hepatitis C virus infection
Fumitake Amemiya et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
Shirit Einav et al.
NATURE BIOTECHNOLOGY (2008)
Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly
Nicole Appel et al.
PLOS PATHOGENS (2008)
NS3 peptide, a novel potent hepatitis C virus NS3 helicase inhibitor:: Its mechanism of action and antiviral activity in the replicon system
Agnieszka Gozdek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model
Chih-Ming Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Hepatitis C virus infection:: in vivo and in vitro models
V. Brass et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
Nicole Forestier et al.
HEPATOLOGY (2007)
NS3 helicase actively separates RNA strands and senses sequence barriers ahead of the opening fork
Wei Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus
Jin Ye
PLOS PATHOGENS (2007)
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus
Eike Steinmann et al.
HEPATOLOGY (2007)
Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions
Eike Steinmann et al.
PLOS PATHOGENS (2007)
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Inhibition of T-cell inflammatory cytokines, hepatocyte NF-κB signaling, and HCV infection by standardized silymarin
Stephen J. Polyak et al.
GASTROENTEROLOGY (2007)
The hepatitis C virus life cycle as a target for new antiviral therapies
Jean-Michel Pawlotsky et al.
GASTROENTEROLOGY (2007)
An analogue of AICAR with dual inhibitory activity against WNV and HCVNTPase/helicase:: Synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl) imidazole-1-β-D-ribofuranoside
Ravi K. Ujjinamatada et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
SCH 503034, a novel hepatitis C virus pro-tease inhibitor, plus pegylated interferon α-2b for genotype 1 nonresponders
Christoph Sarrazin et al.
GASTROENTEROLOGY (2007)
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors
Cynthia Chapel et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
Jacqueline G. O'Leary et al.
HEPATOLOGY (2007)
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate
Martin J. Slater et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Antiviral activity of the non-nucleoside polymerase inhibitor, HCV-796, in combination with pegylated interferon alfa-2b in treatment-naive patients with chronic HCV
S. A. Villano et al.
JOURNAL OF HEPATOLOGY (2007)
A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication
Sun Suk Kim et al.
GASTROENTEROLOGY (2007)
Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor
Anita Y. M. Howe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine
Claire Pierra et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: A phase Ib, placebo-controlled, randomized study
Hendrik W. Reesink et al.
GASTROENTEROLOGY (2006)
Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans
Francois Helle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition
Bichitra K. Biswal et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
In vitro selected Con1 subgenomic replicons resistant to 2′-C-methyl-cytidine or to R1479 show lack of cross resistance
Sophie Le Pogam et al.
VIROLOGY (2006)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus
Sophie Le Pogam et al.
JOURNAL OF VIROLOGY (2006)
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
Xiao Tong et al.
ANTIVIRAL RESEARCH (2006)
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse et al.
HEPATOLOGY (2006)
Searching for a new anti-HCV therapy:: Synthesis and properties of tropolone derivatives
AM Boguszewska-Chachulska et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease
RB Perni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells
BA Malcolm et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture
K Klumpp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCVNS5B RNA dependent RNA polymerase
A Gopalsamy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Treating viral hepatitis C: Efficacy, side effects, and complications
M. P. Manns et al.
GUT (2006)
Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C
A Gordon et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
American Gastroenterological Association technical review on the management of hepatitis C
JL Dienstag et al.
GASTROENTEROLOGY (2006)
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase
G Kukolj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061
C Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
M Nakagawa et al.
GASTROENTEROLOGY (2005)
Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663
G Maga et al.
BIOCHEMISTRY (2005)
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase
K Watashi et al.
MOLECULAR CELL (2005)
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins
A Goffard et al.
JOURNAL OF VIROLOGY (2005)
Identification of FBL2 as a geranylgeranylated required for hepatitis C cellular protein virus RNA replication
CF Wang et al.
MOLECULAR CELL (2005)
Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C
M Reiser et al.
HEPATOLOGY (2005)
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
SB Kapadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061 - Structural analysis indicates different resistance mechanisms
C Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCVNS5B polymerase and HCV subgenomic RNA replication.: Part 2:: Tertiary amides
L Chan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Specific inhibition of hepatitis C virus replication by cyclosporin A
M Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Hepatitis C virus NS5A: tales of a promiscuous protein
A Macdonald et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication
MJ Evans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase
AYM Howe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
H Hinrichsen et al.
GASTROENTEROLOGY (2004)
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro
LJ Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro
G Migliaccio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA
N El-Hage et al.
JOURNAL OF GENERAL VIROLOGY (2003)
The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences
A Sakai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives
BH Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Non-nucleoside analogue inhibitors bind to an allosteric site on HCVNS5B polymerase - Crystal structures and mechanism of inhibition
MT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor
TT Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
P André et al.
JOURNAL OF VIROLOGY (2002)
ER quality control: towards an understanding at the molecular level
L Ellgaard et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
DaliLite workbench for protein structure comparison
L Holm et al.
BIOINFORMATICS (2000)
分享论文
